F.C. Logue

995 total citations
37 papers, 748 citations indexed

About

F.C. Logue is a scholar working on Oncology, Nephrology and Molecular Biology. According to data from OpenAlex, F.C. Logue has authored 37 papers receiving a total of 748 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 14 papers in Nephrology and 12 papers in Molecular Biology. Recurrent topics in F.C. Logue's work include Bone health and treatments (15 papers), Parathyroid Disorders and Treatments (14 papers) and Metabolism, Diabetes, and Cancer (6 papers). F.C. Logue is often cited by papers focused on Bone health and treatments (15 papers), Parathyroid Disorders and Treatments (14 papers) and Metabolism, Diabetes, and Cancer (6 papers). F.C. Logue collaborates with scholars based in United Kingdom and United States. F.C. Logue's co-authors include G. H. Beastall, William D. Fraser, Stephen Gallacher, SJ Gallacher, David Cameron, D S O’Reilly, Iain T. Boyle, Richard Cowan, W.D. Fraser and Stuart H. Ralston and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Clinical Chemistry and Thorax.

In The Last Decade

F.C. Logue

37 papers receiving 710 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F.C. Logue United Kingdom 17 322 281 208 198 125 37 748
J P Bilezikian United States 12 257 0.8× 107 0.4× 372 1.8× 181 0.9× 79 0.6× 19 697
A Vattimo Italy 12 178 0.6× 317 1.1× 62 0.3× 161 0.8× 128 1.0× 43 637
A Caniggia Italy 16 167 0.5× 317 1.1× 90 0.4× 127 0.6× 240 1.9× 80 722
H. G. Haas Switzerland 11 161 0.5× 171 0.6× 81 0.4× 140 0.7× 52 0.4× 42 518
J P Stapleton New Zealand 9 318 1.0× 511 1.8× 65 0.3× 177 0.9× 74 0.6× 11 815
Hang S. Tsao United States 6 201 0.6× 78 0.3× 338 1.6× 191 1.0× 94 0.8× 9 717
Ylva Pernow Sweden 17 246 0.8× 212 0.8× 458 2.2× 153 0.8× 188 1.5× 31 740
Philip G. Rose United States 11 66 0.2× 130 0.5× 102 0.5× 126 0.6× 82 0.7× 14 487
Peter Papapetrou Greece 9 229 0.7× 197 0.7× 41 0.2× 108 0.5× 99 0.8× 23 601
Takeshi Sugishita Japan 8 97 0.3× 172 0.6× 78 0.4× 122 0.6× 46 0.4× 10 443

Countries citing papers authored by F.C. Logue

Since Specialization
Citations

This map shows the geographic impact of F.C. Logue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F.C. Logue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F.C. Logue more than expected).

Fields of papers citing papers by F.C. Logue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F.C. Logue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F.C. Logue. The network helps show where F.C. Logue may publish in the future.

Co-authorship network of co-authors of F.C. Logue

This figure shows the co-authorship network connecting the top 25 collaborators of F.C. Logue. A scholar is included among the top collaborators of F.C. Logue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F.C. Logue. F.C. Logue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fraser, William D., F.C. Logue, Stephen Gallacher, et al.. (1998). Alteration of the circadian rhythm of intact parathyroid hormone and serum phosphate in women with established postmenopausal osteoporosis. Osteoporosis International. 8(2). 121–126. 44 indexed citations
2.
Davidson, Laurie A., et al.. (1996). LUNG TUMOURS IMMUNOREACTIVE FOR PARATHYROID HORMONE RELATED PEPTIDE: ANALYSIS OF SERUM CALCIUM LEVELS AND TUMOUR TYPE. The Journal of Pathology. 178(4). 398–401. 14 indexed citations
3.
Gallacher, Stephen, William D. Fraser, F.C. Logue, et al.. (1994). Changes in calciotrophic hormones and biochemical markers of bone turnover in normal human pregnancy. European Journal of Endocrinology. 131(4). 369–374. 72 indexed citations
4.
Wd, Fraser, et al.. (1994). Alteration of the circadian rhythm of intact parathyroid hormone following a 96‐hour fast. Clinical Endocrinology. 40(4). 523–528. 35 indexed citations
5.
Gallacher, Stephen, et al.. (1994). Acute effects of intravenous 1α-hydroxycholecalciferol on parathyroid hormone, osteocalcin and calcitriol in man. European Journal of Endocrinology. 130(2). 141–145. 6 indexed citations
6.
Gallacher, SJ, W.D. Fraser, M. A. Farquharson, et al.. (1993). Coincidental occurrence of primary hyperparathyroidism and cancer‐associated hypercalcaemia in a middle‐aged man. Clinical Endocrinology. 38(4). 433–437. 12 indexed citations
7.
Gallacher, SJ, BM Fisher, John Quin, et al.. (1993). An Evaluation of Bone Density and Turnover in Premenopausal Women with Type 1 Diabetes Mellitus. Diabetic Medicine. 10(2). 129–133. 61 indexed citations
8.
Fraser, William D., J. Elliott Robinson, Benjamin H. Durham, et al.. (1993). Clinical and laboratory studies of a new immunoradiometric assay of parathyroid hormone-related protein. Clinical Chemistry. 39(3). 414–419. 69 indexed citations
9.
Gallacher, Stephen, et al.. (1992). Factors predicting the acute effect of pamidronate on serum calcium in hypercalcemia of malignancy. Calcified Tissue International. 51(6). 419–423. 11 indexed citations
10.
Gallagher, Stephen J., et al.. (1991). Augmentation of parathyroid 201TI99cm scanning by infusion of trisodium edetate. Nuclear Medicine Communications. 12(9). 793–798. 3 indexed citations
11.
Gallacher, Stephen, et al.. (1991). A comparison of low versus high dose pamidronate in cancer-associated hypercalcaemia. Bone and Mineral. 15(3). 249–256. 15 indexed citations
12.
Logue, F.C., Ben D. Perry, E.M. Biggart, Richard Chapman, & G. H. Beastall. (1991). Production and characterisation of monoclonal antibodies to parathyroid hormone (1–34). Journal of Immunological Methods. 137(2). 159–166. 3 indexed citations
13.
Fraser, W.D., et al.. (1991). Intact parathyroid hormone concentration and cyclic AMP metabolism in thyroid disease. European Journal of Endocrinology. 124(6). 652–657. 10 indexed citations
14.
Merwe, Walter M. van der, R. S. C. Rodger, F.C. Logue, et al.. (1990). Low Calcium Dialysate and High-Dose Oral Calcitriol in the Treatment of Secondary Hyperparathyroidism in Haemodialysis Patients. Nephrology Dialysis Transplantation. 5(10). 874–877. 14 indexed citations
15.
Gallacher, Stephen, William D. Fraser, Uday Patel, et al.. (1990). Breast Cancer-Associated Hypercalcaemia: A Reassessment of Renal Calcium and Phosphate Handling. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 27(6). 551–556. 24 indexed citations
16.
Logue, F.C., W.D. Fraser, SJ Gallacher, et al.. (1990). THE LOSS OF CIRCADIAN RHYTHM FOR INTACT PARATHYROID HORMONE AND NEPHROGENOUS CYCLIC AMP IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM. Clinical Endocrinology. 32(4). 475–484. 24 indexed citations
17.
Logue, F.C., et al.. (1990). The Circadian Rhythm of Intact Parathyroid Hormone-(1–84): Temporal Correlation with Prolactin Secretion in Normal Men. The Journal of Clinical Endocrinology & Metabolism. 71(6). 1556–1560. 22 indexed citations
18.
Logue, F.C., G. H. Beastall, Fraser Wd, & D S O’Reilly. (1990). Intact parathyroid hormone assays.. BMJ. 300(6719). 210–211. 16 indexed citations
19.
Logue, F.C., et al.. (1989). THE CIRCADIAN RHYTHM OF INTACT PARATHYROID HORMONE (1-84) AND NEPHROGENOUS CYCLIC ADENOSINE MONOPHOSPHATE IN NORMAL MEN. Journal of Endocrinology. 121(1). R1–R3. 31 indexed citations
20.
Campbell, John, et al.. (1986). Effect of fenoprofen on thyroid function tests. Clinica Chimica Acta. 161(2). 233–238. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J P Bilezikian Breakdown of academic impact, for papers by A Vattimo Breakdown of academic impact, for papers by A Caniggia Breakdown of academic impact, for papers by H. G. Haas Breakdown of academic impact, for papers by J P Stapleton Breakdown of academic impact, for papers by Hang S. Tsao Breakdown of academic impact, for papers by Ylva Pernow Breakdown of academic impact, for papers by Philip G. Rose Breakdown of academic impact, for papers by Peter Papapetrou Breakdown of academic impact, for papers by Takeshi Sugishita
Rankless by CCL
2026